ABSTRACT Vitamin D deficiency is often unrecognized and has been linked to many chronic diseases. Vitamin D supplementation has been shown to ameliorate these chronic diseases and may reduce the prevalence of some cancers. We analyzed the health care costs associated with vitamin D deficiency in Veterans in Northeast Tennessee. A retrospective electronic chart analysis of the relationship of 25-hydroxyvitamin D [25(OH)D] status to health care costs, services, and utilization was done in 886 veterans. The overall costs were higher by 39% in the vitamin D-deficient group. Vitamin D deficiency was associated with increased service utilization in many areas including more frequent emergency room and clinic visits as well as increased inpatient stay and inpatient services. The serum level of vitamin D was also related to health care costs, although to a lesser extent. Vitamin D deficiency is closely linked to increased health care costs in veterans.
INTRODUCTION
Adequate levels of vitamin D are needed for optimal health. Although the clinical presentations linked to severe vitamin D deficiency have been well recognized, milder degrees of vitamin D deficiency remain an overlooked clinical entity. 1 Hypovitaminosis D is common in patients, including those with vitamin D intakes exceeding the recommended daily allowance and in patients without apparent risk factors for vitamin D deficiency. 2 Vitamin D deficiency has been associated with reduced bone density and increased falls. 3 The falls and associated fractures can be reduced by vitamin D, possibly in a dose-dependent manner. 4 Moreover, vitamin D deficiency is linked to increased prevalence of several types of cancer 5 and increased disease activity in immunologically mediated diseases such as multiple sclerosis 6 and rheumatoid arthritis 7 as well as increased mortality in hemodialysis patients. 8 Enhanced vitamin D status is associated with improved mood 9 and increased well-being 10 and decreased cancer risk in prospective studies. 11 Few studies have examined the prevalence of vitamin D status in veterans. A study in a Wisconsin Veterans Home indicated that 32% of veterans had 25(OH)D levels lower than 30 ng/mL. 12 Similarly, hypovitaminosis D with secondary elevation of parathyroid hormone was evident despite apparently acceptable intake of vitamin D, irrespective of seasonal status in veterans nursing homes. 13 Vitamin D deficiency has also been documented in veterans with spinal cord injury.
14 Although this initial data indicates that the prevalence of vitamin D deficiency in veterans to be similar to the general population, 15 no data exist on the health care costs of vitamin D deficiency in veterans. Given the potential economic impact of vitamin D deficiency, the present study was undertaken to assess the association between vitamin D status and health care costs in veterans.
METHODS

Participants and Procedure
The study was conducted at a Veterans Affairs (VA) facility in the Southeastern United States. The Research and Development committee at the VA Medical Center and the institutional review board at the affiliated university approved the study. Participants included all patients seen at the VA Medical Center from January 1, 2005 to March 31, 2007 with serum 25(OH)D analysis.
Data were obtained electronically through retrospective medical chart review after personal information was redacted. Information collected included 25(OH)D levels as well as health care costs and service utilization for the 24 months preceding the initial 25(OH)D estimate.
The 25(OH)D assay was done by immunochemiluminometric assay (Labcorp, Burlington, North Carolina). Costs were broken down into separate inpatient and outpatient categories (i.e., laboratory, pharmacy, radiology, surgery, primary care, and emergency room). Totals were also extracted for all costs, inpatient costs, and outpatient costs.
The costs were estimated by the technical guidelines via the Decision Support System and clinical National Data Extracts standardized by the VA. 16 For each of the cost categories, a total dollar amount was analyzed. In addition, dichotomous service utilization variables were constructed to represent whether a patient had incurred that type of cost (not all of these variables were used in analyses, since virtually all patients had costs in some of the categories). No cost in a particular category meant that that service was not used. Fees refer to costs incurred by the VA as a result of consultation and/or procedures done in the private sector when such services were inaccessible or unavailable in a timely manner through the VA hospital.
Data Analysis
Vitamin D level was analyzed both as a continuous and a dichotomous variable indicating deficiency. Vitamin D deficiency was defined as a 25(OH)D Ͻ20 ng/mL. 15 Statistical analyses were performed using SPSS (SPSS Inc., version 14.0; Chicago, Illinois). All variables were checked for outliers and normality of distribution before analyses were performed. Correlations, t test, and 2 analysis were used to examine the associations between vitamin D levels and the cost and service utilization variables.
RESULTS
There were 42,588 unique patients seen at the VA facility during the study period and 886 of these had a serum 25(OH)D analysis performed. The mean age of the study group was 66.8 years, with a predominantly male gender (88.6%). The characteristics of the 886 participating patients and the health care parameters studied are shown in Table I . The average participant was male and in his mid-60s, typical of a VA facility population. In addition, the participants were largely Caucasian, representative of the surrounding community. Vitamin D status was not significantly related to age, race, or gender; however, our sample had limited numbers of females and minorities. Although the average vitamin D level was 25.5 ng/mL, more than two in five participants were vitamin D deficient (Ͻ20 ng/mL). Average expenditures in the various categories varied widely; however, the average total medical costs for participants was just under $20,000 for the 24-month period. Participants averaged about one primary care or other clinic visit per month, and the vast majority did not have an inpatient hospitalization. However, the vitamin D-deficient veterans had significantly greater utilization of the emergency room and clinics as shown in Table II . Inpatient hospitalization costs was also significantly higher in the vitamin D-deficient group. As shown in Table III , overall medical expenditures were ϳ39% higher in the vitamin D-deficient group. The significant increase in outpatient and inpatient costs in the vitamin D-deficient group was due to fees, emergency room visits, pharmacy, laboratory, radiology, and primary care expenditures. Surgery costs were not significantly related to vitamin D status either on an inpatient or outpatient basis.
When analyzed as a continuous variable, the 25(OH)D level was inversely related to total costs (Table IV) . Although serum vitamin D levels did not have a significant correlation with outpatient costs, they were significantly inversely correlated with inpatients costs, including laboratory and radiology costs. Similarly, the level of vitamin D deficiency was significantly associated with utilization of emergency room visits and inpatient services, including laboratory, pharmacy, and inpatient hospitalization (Table V) .
DISCUSSION
To our knowledge, this is the first study to demonstrate that vitamin D deficiency was associated with both increased medical care utilization and costs within the veteran population.
Vitamin D deficiency was associated with an increase in all outpatient and inpatient costs, including pharmacy, radiology, and laboratory services as well as higher use of clinics, emergency room, and inpatient hospitalization. The serum vitamin D level was also inversely linked to overall costs, especially inpatient costs, including radiology and laboratory expenditures and a greater number of emergency room visits. However, it was clear that the presence or absence of vitamin D deficiency was more clearly linked to costs and utilization than the serum level of vitamin D. The lack of association between surgery and vitamin D status is interesting and may relate to the fact that surgery costs included anesthesiology and actual surgical costs but not the postoperative expenses. Our data do not address the specific causes of increased health care costs and utilization. It is likely that increased fatigue, decreased clinical well-being, and possibly several chronic ailments such as cancers and autoimmune diseases linked to aging were likely to account for increased health care costs.
The widespread occurrence of vitamin D deficiency in both inpatients and outpatients within the United States is well documented. 2, 17 Vitamin D deficiency has been postulated as a link to many chronic illnesses and as such would be expected to increase costs and use of health care services. It has been proposed that providing 1,000 IU of vitamin D daily for all adult Americans would cost about $1 billion with the expected health benefits, including a reduction in cancer in the range of $16 to 25 billion. 18 Despite increasing evidence of the health benefits of vitamin D, testing for suboptimal vitamin D levels is not widely practiced. Indeed, our own sample of 886 tested patients constitutes ϳ2% of all unique patients seen during the study period and indicates a likely missed target of opportunity to identify and rectify suboptimal vitamin D levels.
There is now excellent scientific evidence that vitamin D does indeed reduce the risk of some cancers 11 and may ameliorate the manifestations of several chronic diseases, 19, 20 possibly through an immunomodulatory function. 21 Studies also indicate that vitamin D may enhance longevity. 22 It is likely that vitamin D requirements need to be much higher than the currently recommended dose, especially during winter months. An intake of 100 g (4000 IU)/day of vitamin D may be safe and physiologic. 10 There is also some preliminary data that suggest that enhanced vitamin D status may have a positive impact on chronic illnesses such as diabetes, 23 hypertension, 24 and heart failure, 25 which are widely prevalent in the veteran population. The possibility that vitamin D may also have other less well-recognized benefits such as improving outcomes in the event of a flu epidemic remains an intriguing concept. 26 In the present study, there was a more than $3,262 annual premium in costs in vitamin D-deficient patients. Approximate calculations based on 30% prevalence of vitamin D deficiency in the 5.5 million unique veterans seen at VA facilities in 2006 indicates a significant potential savings in the VA health care budget. Moreover, the annual cost of vitamin D supplementation, including two 25(OH)D assays, would be less than $100 annually per patient. Increased awareness and testing could result in lower costs through in-house estimation with a more rapid return of abnormal laboratory values to clinicians. Our study has certain limitations inherent in retrospective data analysis. The single estimate of serum vitamin D, while providing valuable information, is less optimal than repeated serial estimates. Our population sample was predominantly male and Caucasian and reflected a population at a latitude of ϳ36 degrees. It is possible that veterans in sunnier climates may not experience similar findings. It is interesting to note, however, that merely living in a sunnier climate does not afford protection against vitamin D deficiency, as deficiency has been reported in southern Florida 27 and Australia. 28 Given the nature of the study, we cannot conclude causality and it is possible that veterans with illness then develop vitamin D deficiency, rather than the reverse. This is a less likely scenario based on current knowledge, including the widespread deficiency of vitamin D and the increasing benefit documented with D supplementation. 15 It is also likely that some veterans also incurred health care costs by concurrently attending private health care facilities and this could not be estimated in our analysis.
In conclusion, vitamin D deficiency is significantly associated with both inpatient and outpatient health care expenditures and service utilization in veterans seeking care in Northeast Tennessee. The increased expenditures spanned laboratory, pharmacy, and radiology costs as well as utilization of clinics and number of hospital admissions. Although the present study does not address the reasons for vitamin D deficiency in veterans, it is likely that inadequate sunlight exposure and intake of vitamin D are both major contributory factors. We recommend that clinicians consider lowering the threshold for testing for vitamin D deficiency since the optimal requirement is significantly greater than current recommendations. 15 A widespread program of food fortification may be needed to ensure adequate vitamin D intake. 29 The potential for reducing inpatient hospitalization and associated cost savings is especially noteworthy given the transition of the VA to a predominantly outpatient setting. The potential for improving the quality of life of veterans with a concomitant reduction in health care delivery costs by inexpensive vitamin D supplementation offers exciting new research and clinical potential. Future prospective studies are urgently needed to confirm these findings and may have broad applicability. 
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